Our study demonstrated that chronic administration of Ang II significantly increased the expression of cardiac chymase, chymase-containing mast cells, TGF-β1, and MMP-2, all of which are associated with the development of cardiac hypertrophy, fibrosis, and diastolic dysfunction. The gene discussed is MMP2; the disease is cardiac hypertrophy.